HomePTGX • NASDAQ
add
Protagonist Therapeutics Inc
Previous close
$59.68
Day range
$58.75 - $60.40
Year range
$33.34 - $61.89
Market cap
3.66B USD
Avg Volume
816.67K
P/E ratio
82.84
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 5.55M | 33.09% |
Operating expense | 47.59M | 10.77% |
Net income | -34.77M | -13.57% |
Net profit margin | -626.96 | 14.67% |
Earnings per share | -0.55 | -10.00% |
EBITDA | -41.74M | -8.26% |
Effective tax rate | -0.50% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 570.46M | 1.15% |
Total assets | 718.01M | 16.82% |
Total liabilities | 49.99M | -31.81% |
Total equity | 668.02M | — |
Shares outstanding | 62.21M | — |
Price to book | 5.55 | — |
Return on assets | -14.40% | — |
Return on capital | -15.24% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -34.77M | -13.57% |
Cash from operations | -28.78M | -110.71% |
Cash from investing | 54.81M | 162.20% |
Cash from financing | 2.92M | 13.72% |
Net change in cash | 28.96M | -84.18% |
Free cash flow | -16.08M | -105.63% |
About
Founded
2006
Headquarters
Website
Employees
130